Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy

Singhal, Deepika; Desai, Roopali; Desai, Sejal; Shastri, Manisha; Saxena, Deepak

doi:10.4103/0976-500x.81902

Cited by 10 publications

(15 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As mentioned in the manuscript, that sample size was purposive based on operational feasibility. [ 1 ] We agree with the reader's comment about possible elaboration of the statistical tests applied, but keeping in view the word limits, mandate of the Journal of Pharmacology and Pharmacotherapeutics and the peers who would follow the article as well the journal, it was decided to give more emphasis on content, result and discussion on the use of topical brimonidine to prevent intraocular pressure (IOP) elevations following Nd:YAG-laser posterior capsulotomy. [ 2 ] As rightly mentioned by the reader, ciprofloxacin group acts as the placebo arm in this superiority trial and various other drugs used in glaucoma such as acetazolamide, timolol, pilocarpine and so on have established efficacy for such post laser IOP spikes since many years now.…”

mentioning

confidence: 88%

mentioning

confidence: 88%

“…We would like to thank the reader for showing interest in the article titled “Use of topical brimonidine to prevent intraocular pressure (IOP) elevations following Nd:YAG-laser posterior capsulotomy” and appreciating the need to manage the raised IOP after Nd:YAG-laser posterior capsulotomy as narrated in the manuscript. [ 1 ]…”

mentioning

confidence: 99%

See 2 more Smart Citations

Authors′ reply

Singhal¹,

Desai²,

Desai³

et al. 2012

J Pharmacol Pharmacother

Self Cite

View full text Add to dashboard Cite

mentioning

confidence: 88%

mentioning

confidence: 88%

See 1 more Smart Citation

Authors′ reply

Singhal¹,

Desai²,

Desai³

et al. 2012

J Pharmacol Pharmacother

Self Cite

View full text Add to dashboard Cite

“…These mechanisms cause alteration in aqueous drainage and a resultant increase in IOP occurs. 7,8,9 Patients & Methods A Descriptive case series study was being conducted at the Ophthalmology Department, Rawalpindi Medical University. The study was completed within 6 months from 21.02.15 to 21.08.15.…”

Section: Introductionmentioning

confidence: 99%

Frequency of Raised Intraocular Pressure and its Correlations to the energy used following Neodymium YAG Laser Posterior Capsulotomy in Pseudophakes

Zubair¹,

Kant²,

Baloch³

et al. 2020

JRMC

View full text Add to dashboard Cite

Objective: To determine the frequency of raised intraocular pressure in pseudophakic undergoing Nd YAG laser posterior capsulotomy. To compare the frequency of raised intraocular pressure in pseudophakic undergoing high and low energy Nd YAG laser posterior capsulotomy Methods: This Descriptive case series included 140 patients with pseudophakic posterior capsular opacity. After dilating the pupils with tropicamide Nd YAG laser posterior capsulotomy was performed and the total amount of energy used was noted. The frequency of raised IOP in post-laser patients and comparison of frequencies of raised IOP undergoing high and low energy Nd YAG laser posterior capsulotomies (≤ 50 MJ labeled as low energy and > 50 MJ labeled as high energy) were calculated Results: The mean age was 57.37 ±8.74. Mean pre laser IOP was 15.15 and post-laser IOP was 17.50. The rise in IOP was normal in 82.9% and raised in 17.1%. In lower energy group normal IOP was found in 35.7% and raised in 2.9%. In a higher energy group, normal IOP was found in 47.1%, and raised IOP was found to be 14.3%. Conclusion: Higher the energy used during the Nd YAG laser posterior capsulotomy procedure, more is the chance of a rise in post-laser intraocular pressure as compared to those in which lesser energy was being used.

show abstract

“…[1] The authors have rightly highlighted the need to manage the raised IOP after Nd:YAG-laser posterior capsulotomy. However, I would like to bring to the fore a few observations.…”

mentioning

confidence: 99%

Prophylactic ocular hypotensives before Nd: YAG laser posterior capsulotomy

Dubey

2012

Journal of Pharmacology and Pharmacotherapeutics

View full text Add to dashboard Cite

laboratory required) to formulate a drug based on:-• Chemical: In the chemical section of the Pharmacology Department or in the Department of Organic and Applied Chemistry. • Plant extract and / or fractions of its components.• A brief introduction to in-silico techniques.• These drugs may be used in the experimental projects of the students in the following year, for screening purposes. InfrastructureChemistry laboratory for a student group of 10 to 20 each, plant extraction instruments, and a computer with internet facilities. EvaluationEnd-of-session presentation on their drug, including its method of discovery and formulation, followed by viva.The proposed module will help the students cover major treatment protocols and prescription writing for common emergency, sub-acute, and chronic IPD diseases, as instructed in the CAL laboratory and evening prescription teaching. Furthermore, the students will also be able to use various drug delivery devices according to different routes of drug administration in emergency and non-emergency settings, as taught in the clinical pharmacology laboratory. The new generation of CAL laboratories will provide opportunities to students to make 'life-saving decisions' in simulated stressful conditions.Working in groups will enhance their leadership quality, mutual respect, and ability to divide work for effective patient care. The proposed training module will also enable the students to have a basic knowledge on clinical research, research methodology, and drug development.

show abstract

Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy

Cited by 10 publications

References 7 publications

Authors′ reply

Authors′ reply

Frequency of Raised Intraocular Pressure and its Correlations to the energy used following Neodymium YAG Laser Posterior Capsulotomy in Pseudophakes

Prophylactic ocular hypotensives before Nd: YAG laser posterior capsulotomy

Contact Info

Product

Resources

About